ACTPA_OULOR
ID ACTPA_OULOR Reviewed; 165 AA.
AC Q5I4B8;
DT 30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT 15-FEB-2005, sequence version 1.
DT 03-AUG-2022, entry version 63.
DE RecName: Full=DELTA-actitoxin-Oor1a {ECO:0000303|PubMed:22683676};
DE Short=DELTA-AITX-Oor1a {ECO:0000303|PubMed:22683676};
DE AltName: Full=Actinoporin Or-A {ECO:0000303|PubMed:15787212, ECO:0000303|PubMed:16119454};
DE AltName: Full=Cytolysin Or-A {ECO:0000303|PubMed:15787212};
OS Oulactis orientalis (Japan anemone).
OC Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
OC Actiniidae; Oulactis.
OX NCBI_TaxID=308032;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=16119454;
RA Il'ina A.P., Monastyrnaia M.M., Isaeva M.P., Guzev K.V., Rasskazov V.A.,
RA Kozlovskaya E.P.;
RT "Primary structures of actinoporins from sea anemone Oulactis orientalis.";
RL Bioorg. Khim. 31:357-362(2005).
RN [2]
RP PROTEIN SEQUENCE OF 1-8.
RX PubMed=15787212;
RA Il'ina A.P., Monastyrnaia M.M., Sokotun I.N., Egorov T.A., Nazarenko I.A.,
RA Likhatskaia G.N., Kozlovskaya E.P.;
RT "Actinoporins from the Sea of Japan anemone Oulactis orientalis: isolation
RT and partial characterization.";
RL Bioorg. Khim. 31:39-48(2005).
RN [3]
RP 3D-STRUCTURE MODELING.
RX PubMed=20692277; DOI=10.1016/j.toxicon.2010.07.011;
RA Monastyrnaya M., Leychenko E., Isaeva M., Likhatskaya G., Zelepuga E.,
RA Kostina E., Trifonov E., Nurminski E., Kozlovskaya E.;
RT "Actinoporins from the sea anemones, tropical Radianthus macrodactylus and
RT northern Oulactis orientalis: comparative analysis of structure-function
RT relationships.";
RL Toxicon 56:1299-1314(2010).
RN [4]
RP REVIEW.
RX PubMed=19268680; DOI=10.1016/j.toxicon.2009.02.026;
RA Kristan K.C., Viero G., Dalla Serra M., Macek P., Anderluh G.;
RT "Molecular mechanism of pore formation by actinoporins.";
RL Toxicon 54:1125-1134(2009).
RN [5]
RP NOMENCLATURE.
RX PubMed=22683676; DOI=10.1016/j.toxicon.2012.05.020;
RA Oliveira J.S., Fuentes-Silva D., King G.F.;
RT "Development of a rational nomenclature for naming peptide and protein
RT toxins from sea anemones.";
RL Toxicon 60:539-550(2012).
CC -!- FUNCTION: Pore-forming protein that forms cations-selective hydrophilic
CC pores of around 1 nm and causes cardiac stimulation and hemolysis. Pore
CC formation is a multi-step process that involves specific recognition of
CC membrane sphingomyelin (but neither cholesterol nor
CC phosphatidylcholine) using aromatic rich region and adjacent
CC phosphocholine (POC) binding site, firm binding to the membrane (mainly
CC driven by hydrophobic interactions) accompanied by the transfer of the
CC N-terminal region to the lipid-water interface and finally pore
CC formation after oligomerization of monomers. Cytolytic effects include
CC red blood cells hemolysis, platelet aggregation and lysis, cytotoxic
CC and cytostatic effects on fibroblasts. Lethality in mammals has been
CC ascribed to severe vasospasm of coronary vessels, cardiac arrhythmia,
CC and inotropic effects. {ECO:0000250}.
CC -!- SUBUNIT: Tetramer in the presence of a lipidic interface. Monomer, in
CC soluble state (By similarity). {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Secreted. Nematocyst. Target cell membrane
CC {ECO:0000250}. Note=Forms an alpha-helical membrane channel in the
CC prey. {ECO:0000250}.
CC -!- DOMAIN: The N-terminal region, before the pore is formed, is bound to
CC the lipid membrane. It partitions into the lipid-water interface and
CC stabilizes the monomeric molecule on the membrane. Finally, it
CC traverses the bilayer, thus forming the transmembrane pore.
CC {ECO:0000250|UniProtKB:P61914}.
CC -!- SIMILARITY: Belongs to the actinoporin family. Sea anemone subfamily.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AY856481; AAW48528.1; -; mRNA.
DR AlphaFoldDB; Q5I4B8; -.
DR SMR; Q5I4B8; -.
DR TCDB; 1.C.38.1.4; the pore-forming equinatoxin (equinatoxin) family.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0042151; C:nematocyst; IEA:UniProtKB-SubCell.
DR GO; GO:0046930; C:pore complex; IEA:InterPro.
DR GO; GO:0015267; F:channel activity; IEA:InterPro.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR GO; GO:0006812; P:cation transport; IEA:InterPro.
DR GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR GO; GO:0046931; P:pore complex assembly; IEA:InterPro.
DR Gene3D; 2.60.270.20; -; 1.
DR InterPro; IPR009104; Anemon_actinoporin-like.
DR InterPro; IPR015926; Cytolysin/lectin.
DR Pfam; PF06369; Anemone_cytotox; 1.
DR SUPFAM; SSF63724; SSF63724; 1.
PE 1: Evidence at protein level;
KW Cytolysis; Direct protein sequencing; Hemolysis; Ion transport; Membrane;
KW Nematocyst; Secreted; Target cell membrane; Target membrane; Toxin;
KW Transmembrane; Transport.
FT CHAIN 1..165
FT /note="DELTA-actitoxin-Oor1a"
FT /id="PRO_0000239261"
FT REGION 1..17
FT /note="N-terminal region"
FT /evidence="ECO:0000250"
FT REGION 92..107
FT /note="Trp-rich region, which is important for the binding
FT to lipid membrane"
FT /evidence="ECO:0000250|UniProtKB:P61914"
FT BINDING 41
FT /ligand="phosphocholine"
FT /ligand_id="ChEBI:CHEBI:295975"
FT /evidence="ECO:0000250"
FT BINDING 74
FT /ligand="phosphocholine"
FT /ligand_id="ChEBI:CHEBI:295975"
FT /evidence="ECO:0000250"
FT BINDING 92
FT /ligand="phosphocholine"
FT /ligand_id="ChEBI:CHEBI:295975"
FT /evidence="ECO:0000250"
FT BINDING 94
FT /ligand="phosphocholine"
FT /ligand_id="ChEBI:CHEBI:295975"
FT /evidence="ECO:0000250"
FT BINDING 125
FT /ligand="phosphocholine"
FT /ligand_id="ChEBI:CHEBI:295975"
FT /evidence="ECO:0000250"
FT SITE 100
FT /note="Important in the initial contact with the lipid
FT membrane"
FT /evidence="ECO:0000250"
SQ SEQUENCE 165 AA; 17886 MW; 2066C005AB9A9F1E CRC64;
ATFRVLAKVL AELGKVSRKI AVGVDNESGG SWTALNAYFR SGTTDVILPD LVPNQKALLY
RGGKDTGPVA TGVVGVLAYA MSDGNTLAIL FSVPYDYNLY SNWWNVKVYS GKRRADQGMS
EDLSYGNPYG GDNGWHARKL AYGLKERGFM KSSAQSILEI HATKA
